ArticleBiology2019

Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells.

Yuanyuan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.